LDL Reduction: Studies have found that this therapy successfully reduced LDL cholesterol by up to 62 percent. Let's explain it in detail.

Treating bad cholesterol with gene therapy

How Gene Therapy Reduces LDL Cholesterol: Scientists have raised great hope for millions of people suffering from heart disease and bad cholesterol. Scientists claim that a treatment is being developed in which a single dose of gene therapy can keep bad cholesterol under control for a long time. If the results are successful in upcoming large trials, many patients may not need to take cholesterol medication for the rest of their lives.

Does this really work?

Scientists have conducted research on a new gene therapy, Verve-102, and the results have been published in a prestigious medical journal. The study found that this therapy was successful in reducing bad LDL cholesterol in the body by up to 62 percent. This research was conducted on patients who had high cholesterol from birth or were at increased risk of heart disease at a young age. A total of 35 patients were included in the initial trial. Scientists observed that in patients who received a higher dose, LDL cholesterol levels decreased by an average of 78 mg/dL. Most importantly, the effect lasted for up to a year in many patients.

Very important for heart diseases

Dr. Ambuj Roy, Professor of Cardiology at the All India Institute of Medical Sciences, Delhi, described this study as extremely important for the treatment of heart disease. He said that this research proves that in-vivo base editing of the PCSK9 gene can reduce LDL cholesterol in the body for a long time. If its long-term safety is proven in the future, it could bring about a major change in the treatment of heart disease.

How does gene therapy work in the body?

According to the scientists, this therapy permanently disables a gene called PCSK9 in the liver, which plays a key role in controlling cholesterol levels in the body, using advanced base editing technology, which is considered a more precise and modern method of gene editing.

How is bad cholesterol dangerous for us?

High LDL cholesterol is considered a major cause of heart attacks, strokes, and blockages worldwide. Many patients remain unaffected despite medication. Scientists hope this new therapy could pave the way for a one-time treatment in the future. Fortunately, initial trials revealed no major safety concerns. The pharmaceutical company involved in the research has stated that it will begin Phase 2 clinical trials of Verv-102 this year.